Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$26.12 - $34.07 $29,959 - $39,078
1,147 Added 0.35%
327,844 $11.2 Million
Q1 2024

May 08, 2024

BUY
$26.64 - $40.31 $193,060 - $292,126
7,247 Added 2.27%
326,697 $11.5 Million
Q4 2023

Feb 06, 2024

BUY
$19.95 - $31.0 $302,721 - $470,394
15,174 Added 4.99%
319,450 $9.23 Million
Q3 2023

Nov 08, 2023

BUY
$21.33 - $59.42 $794,841 - $2.21 Million
37,264 Added 13.96%
304,276 $6.97 Million
Q2 2023

Aug 09, 2023

BUY
$34.33 - $62.11 $1.91 Million - $3.46 Million
55,642 Added 26.32%
267,012 $15.3 Million
Q1 2023

May 11, 2023

BUY
$26.01 - $48.69 $5,514 - $10,322
212 Added 0.1%
211,370 $7.96 Million
Q4 2022

Feb 13, 2023

BUY
$24.14 - $30.37 $109,450 - $137,697
4,534 Added 2.19%
211,158 $5.65 Million
Q3 2022

Nov 14, 2022

BUY
$22.23 - $33.37 $315,532 - $473,653
14,194 Added 7.38%
206,624 $5.85 Million
Q2 2022

Aug 15, 2022

BUY
$19.74 - $43.01 $263,055 - $573,151
13,326 Added 7.44%
192,430 $4.18 Million
Q1 2022

May 13, 2022

BUY
$36.25 - $52.02 $168,453 - $241,736
4,647 Added 2.66%
179,104 $7.19 Million
Q4 2021

Feb 11, 2022

BUY
$43.27 - $65.72 $270,004 - $410,092
6,240 Added 3.71%
174,457 $8.27 Million
Q3 2021

Nov 16, 2021

BUY
$53.61 - $67.5 $2.9 Million - $3.65 Million
54,061 Added 47.36%
168,217 $9.53 Million
Q2 2021

Aug 16, 2021

BUY
$45.13 - $64.99 $685,524 - $987,198
15,190 Added 15.35%
114,156 $6.55 Million
Q1 2021

May 17, 2021

BUY
$29.77 - $84.85 $674,439 - $1.92 Million
22,655 Added 29.69%
98,966 $6.26 Million
Q4 2020

Feb 16, 2021

BUY
$25.66 - $34.55 $83,087 - $111,872
3,238 Added 4.43%
76,311 $2.56 Million
Q3 2020

Nov 13, 2020

BUY
$22.51 - $30.11 $332,067 - $444,182
14,752 Added 25.29%
73,073 $2 Million
Q2 2020

Aug 14, 2020

BUY
$12.65 - $29.57 $158,125 - $369,625
12,500 Added 27.28%
58,321 $1.58 Million
Q1 2020

May 15, 2020

BUY
$10.84 - $20.85 $138,340 - $266,087
12,762 Added 38.6%
45,821 $673,000
Q4 2019

Feb 07, 2020

BUY
$13.02 - $19.5 $5,012 - $7,507
385 Added 1.18%
33,059 $568,000
Q3 2019

Nov 08, 2019

BUY
$17.46 - $29.05 $570,488 - $949,179
32,674 New
32,674 $592,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.